Thomas Gad serves as Executive at Y-mAbs Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Thomas Gad has executed 156 insider transactions totaling $47.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 3, 2019 involved selling 4,000 shares valued at $80.1K.
Thomas Gad currently holds 181,531 shares of Y-mAbs Therapeutics, Inc. (YMAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Gad has been a net seller of YMAB stock. They have purchased $0 and sold $47.4M worth of shares.
Thomas Gad's most recent insider trade was on Jun 3, 2019, when they sold 4,000 shares at $20.03 per share.
Get notified when new Form 4 filings are submitted
| $20.21 |
| Discretionary |
| May 13, 2019 | YMAB | $123.7K | Sale | 6,000 | $20.61 | Discretionary |
| Apr 11, 2019 | YMAB | $3.9M | Sale | 150,000 | $25.80 | Discretionary |
| Apr 9, 2019 | YMAB | $2.6M | Sale | 99,200 | $26.02 | Discretionary |
| Apr 9, 2019 | YMAB | $21.5K | Sale | 800 | $26.93 | Discretionary |